This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit March 11, 2015

Not an AzPA member?

Not an AzPA member? Join the only statewide association representing all pharmacy professionals in all pharmacy practice settings.

Stay connected with AzPA!

 Like us on Facebook

 Follow us on Twitter



NEW AzPA Women's Reproductive Health Certificate Program
We are excited to unveil our new certificate program April 25 in Phoenix. Topics will focus on the management and care of commonly encountered female reproductive issues such as contraception, menstrual disorders, infertility and pregnancy. Register at! Bonus: Participating pharmacists will receive $50 promo code to use toward Annual Convention registration. Use this flyer to share with your colleagues!
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

2015 AzPA Annual Convention OPEN FOR REGISTRATION
Join us for three days of continuing education and networking June 26-28 at the Westin La Paloma Resort & Spa in Tucson. Choose to attend the full conference, or specify a single day. AzPA members receive a reduced rate. Not a member? Don’t worry. Your three-day convention rate includes one year AzPA membership. Register now at
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  Be a part of Innovation!

Banner Pharmacy Services will be recognized nationally as a clinical leader and trusted partner in providing innovative pharmacy services and coordinated patient care through convenient access and improved medication outcomes across the continuum.

Click here for Leadership opportunities



Date Event
April 25 Women's Health Certificate Program
June 25 Psychiatric Certificate Program
June 25 Diabetes Care Certificate Program
June 25 Immunization Certificate Program
June 25 NEW APhA Pharmacy-Based Cardiovascular Disease Risk Management
June 26-28 AzPA Annual Convention
June 28 Arizona Pharmacy Foundation Fun Run (more details coming soon)
Sept. 25 Anticoagulation Certificate Program
Sept. 25 Medication Therapy Management Certificate Program
Sept. 26 Fall Conference

Click here for a full event list.


Novel anticoagulants target cancer patients with CVC
By Dr. Afsaneh Motamed-Khorasani
Anticoagulants have been traditionally used to treat venous thromboembolism, which is a major healthcare problem. Sometimes, there is a need in cancer patients to have a central venous catheter, which could in turn increase the chance of thrombosis. Therefore, the potential for the use of parenteral anticoagulants is being studied in ambulatory cancer patients undergoing chemotherapy, radiation or hormonal therapies that otherwise lack the prophylactic or therapeutic indication for the use of these category of drugs.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Influenza hits older adults hard this season
The CDC reports that influenza activity in the United States was elevated as of Feb. 21, with further activity expected for several more weeks. Influenza A viruses have predominated, and older adults have been the hardest hit. Adults aged 65 and older also account for most of the deaths related to pneumonia and influenza, CDC said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Antidepressant medication may help lower stroke, coronary artery disease risks
Tech Times
Medications prescribed to treat depression could have an additional benefit for cardiovascular health by reducing risks of heart disease, researchers say.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Miss an issue of the AzPA Pharmacy Flash? Click here to visit the AzPA Pharmacy Flash archive page.

FDA launches drug shortages mobile app
Pharmacy Practice News
The FDA launched its first free mobile app specifically designed to speed public access to valuable information about drug shortages.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Despite broad awareness, only half of doctors use prescription drug monitoring programs
Medical News Today
In a new survey, researchers at the Johns Hopkins Bloomberg School of Public Health found that physicians report relatively high awareness of state databases that track drug prescriptions but more than one-fifth indicated they were not aware of their state's program at all.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    Could Claritin cure Lyme disease? (Pharmacy Times)
Are there too many pharmacy schools? (By Jason Poquette)
Medication Synchronization: Passed in the Senate Feb. 23 (AzPA)
Bill would allow psychologists to prescribe medication (KTVB-TV)

Don't be left behind. Click here to see what else you missed.

Spider venom has strong painkiller potential
By Dorothy L. Tengler
Chronic pain is a serious health problem that affects more Americans than diabetes, heart disease and cancer combined. Part of the search for new pain-killing drugs has focused on the world's 45,000 species of spiders, many of which kill their prey with venoms that contain hundreds and even thousands of protein molecules, some of which block nerve activity. A new study in the British Journal of Pharmacology suggests that spider venom could lead to a more effective treatment for the millions suffering with chronic pain.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
Looking for similar articles? Search here, keyword PAINKILLER.

COPD counseling takes center stage
Pharmacy Times
Leonard Nimoy's recent death from end-stage chronic obstructive pulmonary disease brought the condition into the spotlight, and may bring patients with questions to the pharmacy counter.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

FDA approves Zarxio, 1st US biosimilar
Pharmacy Practice News
The FDA recently approved Zarxio, the brand name of Sandoz's first biosimilar of filgrastim in this country. The approval includes all the same indications as the reference product Neupogen, made by Amgen.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


AzPA Pharmacy Flash
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Danielle Wegert, Assistant Executive Editor, 469.420.2696   
Contribute news

Disclaimer: The AzPA Pharmacy Flash is a weekly roundup of articles of interest to pharmacists and pharmacy professionals. This email may contain an advertisement of AzPA and/or third party products and services. Opinions expressed in these articles do not necessarily reflect the views of AzPA or its advertising partners. The AzPA Pharmacy Flash is compiled by MultiBriefs, a division of MultiView, Inc. Factual errors are the responsibility of the listed publication.

This edition of the AzPA Pharmacy Flash was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
March 4, 2015
Feb. 25, 2015
Feb. 18, 2015
Feb. 11, 2015

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063